Soybean P34

Soybean P34 Protein Recombinant
Shipped with Ice Packs
In Stock

Description

Biochemical Properties of Soybean P34

Structure:

  • Molecular weight: 28.6 kDa (calculated) / ~32 kDa (observed via SDS-PAGE due to glycosylation) .

  • Isoelectric point: 4.5 .

  • Classification: Thiol protease of the papain family, but lacks enzymatic activity due to the absence of a catalytic cysteine residue .

Expression and Localization:

  • Constitutes 2–3% of total soybean seed protein .

  • Stored in protein storage vacuoles of soybean cotyledons .

Biophysical Stability:

  • Stable at 4°C for 1 week but requires storage below -18°C for long-term preservation .

Clinical Significance

  • Recognized by IgE antibodies in 33–66% of soybean-allergic patients .

  • Cross-reacts with bovine casein, explaining allergic reactions in milk-sensitive individuals .

Immune Response Mechanisms

  • Binds IgE antibodies, triggering mast cell degranulation and basophil activation .

  • Induces Th2 cytokine secretion (IL-5, IL-13) in sensitized mice, confirming its immunodominant role .

Genetic and Agronomic Approaches

MethodEffect on P34Outcome
Gene silencingComplete eliminationHypoallergenic soybeans with unaltered yield .
Marker-assisted selection50–70% reductionLow-P34 lines validated via LC-MS/MS .
Cross-breedingPartial reductionIntrogression into commercial cultivars .

Food Processing Techniques

TechniqueEffectivenessReferences
Enzymatic hydrolysisHigh (cleaves epitopes)
FermentationModerate
Heat treatmentVariable (depends on temperature)

Recombinant P34 Production

  • Expressed in E. coli with His or GST tags for research use .

  • Retains allergenicity and structural integrity comparable to native P34 .

Evolutionary Adaptation

  • Evolved from a functional cysteine protease to a syringolide receptor involved in plant defense signaling .

  • Binds syringolide, an elicitor of hypersensitive responses in resistant soybean cultivars .

Hypoallergenic Soybean Development

  • Transgenic P34-silenced soybeans show no compensatory emergence of new allergens .

  • Challenges: Requires clinical trials to confirm safety for human consumption .

Cross-Reactivity Risks

  • P34 shares epitopes with bovine casein, necessitating caution in soy-based formulas for milk-allergic patients .

Research Gaps and Future Directions

  • Functional ambiguity: P34’s physiological role in soybean remains unclear despite its allergenic prominence .

  • Clinical validation: Hypoallergenic soybeans require human trials to assess efficacy .

Product Specs

Introduction
Soybean protein P34 is a significant allergen for individuals with soybean sensitivities. As a thiol protease within the papain family, it exists as a monomeric allergen. Its N-terminal amino acid sequence and composition mirror that of the 34kDa seed protein. This insoluble glycoprotein, with a pI of 4.5 and a calculated mass of 28.643 Dalton, constitutes 2-3% of the total soybean protein content. Glycosylation increases its mass, resulting in a band of approximately 32kDa on non-reduced SDS-PAGE gels. Notably, it lacks enzymatic function due to the absence of the catalytic cysteine. P34 is localized within storage vacuoles of soybean cotyledons.
Description
The recombinant Soybean P34 protein, derived from E. coli, encompasses the full length of the protein and has a molecular weight of 30 kDa. A His tag is fused to the C-terminus of the protein.
Purity
The protein purity exceeds 90% as determined by SDS-PAGE analysis.
Physical Appearance
The product is a sterile-filtered, colorless solution.
Formulation
The protein is formulated in 1X PBS at a pH of 7.2 and 50% glycerol.
Stability
For optimal stability, Soybean P34 should be stored below -18°C. While it can remain stable at 4°C for up to one week, it is recommended to avoid repeated freeze-thaw cycles.
Source
E.Coli.
Purification Method

Purified by proprietary chromatographic technique

Q&A

What is soybean P34 and what are its structural characteristics?

P34 is a monomeric insoluble glycoprotein with an isoelectric point of 4.5. Its amino acid-based calculated mass is 28.643 kDa, though in its glycosylated form it appears as a ~32 kDa band on non-reduced SDS-PAGE gels. Structurally, it belongs to the papain superfamily of thiol proteases, though it lacks catalytic cysteine and therefore exhibits no enzymatic function . In plant cells, P34 associates with soybean oil bodies despite having no membrane insertion region and is stored in storage vacuoles of soybean cotyledons .

The protein undergoes post-translational modifications where it loses pre- and pro-protein regions containing one glycosylation site. During seedling growth, a basic decapeptide is removed from the structure . Under non-reducing conditions, P34 can form dimers of approximately 58 kDa due to disulfide bridges and attaches to the 7S globulin fraction .

How prevalent is P34 in different soybean varieties and what is its distribution in the seed?

P34 represents approximately 2-3% of total soybean protein across most conventional varieties . It is primarily stored in protein storage vacuoles (PSVs) of soybean cotyledons. When plant cells are disrupted during processing, P34 associates with oil bodies, which has implications for its extraction and isolation .

Recently, two soybean germplasm accessions (PI 567476 and PI 603570A) were identified as having significantly reduced P34 content without other changes in seed protein composition . These naturally occurring low-P34 variants provide valuable research materials for comparative studies and potential development of hypoallergenic soybean varieties.

What is the genetic basis for the low-P34 trait in some soybean accessions?

Research has revealed that the low-P34 trait in soybean accessions PI 567476 and PI 603570A is associated with a specific genetic mutation - a four-basepair insertion at the P34 start codon . This insertion appears to inhibit efficient translation initiation of the P34 protein, resulting in significantly reduced P34 expression levels .

Inheritance studies have confirmed that the mutant P34 alleles completely associate with the low-P34 phenotype, making this a reliable genetic marker. Based on this discovery, molecular markers have been developed to facilitate breeding for the low-P34 trait . This represents a significant advancement in potential development of hypoallergenic soybean varieties through conventional breeding approaches rather than through genetic engineering.

How can researchers effectively screen for the low-P34 trait in breeding programs?

Researchers can implement several complementary approaches:

  • Molecular marker screening: Using markers developed based on the four-basepair insertion at the P34 start codon enables direct selection for mutant P34 alleles .

  • Protein quantification: Extracting proteins from soybean seeds and quantifying P34 levels using techniques such as:

    • Western blotting with P34-specific antibodies

    • ELISA-based quantification methods

    • Mass spectrometry-based proteomics approaches

  • Inheritance analysis: When crossing low-P34 accessions with conventional varieties, the inheritance pattern of the mutant P34 alleles can be tracked to confirm trait transmission .

These screening methods can be applied at different stages of breeding programs, from early generation selection to advanced line validation.

What are the most effective methods for purifying soybean P34 for research purposes?

Several purification strategies have been developed, with hydrophobic interaction chromatography (HIC) emerging as a particularly effective approach:

Extraction from oil bodies method:

  • Extract P34 from washed soybean oil body pads using 0.1 M sodium carbonate buffer

  • Diafiltrate the solution to prepare for chromatographic separation

  • Apply the solution to a Butyl Sepharose 4 FF column

  • Use a two-step gradient elution with ammonium sulphate:

    • First elution: 0.6 M (NH₄)₂SO₄

    • Second elution: 0.4 M (NH₄)₂SO₄ (yields highly pure P34)

  • Alternatively, use a one-step gradient which gives comparable purification in shorter process time

  • Dialyze the collected P34 fractions using membranes with a molecular cut-off of 6-8 kDa to further increase purity

This HIC method has been successfully scaled up from small 1 mL columns to 7.5 mL and 75 mL columns, allowing for product purities approaching 100% with a yield of 27% for the chromatographic separation step .

An alternative approach based on globulin fractionation using Con A Sepharose has also been reported, though the HIC method appears to achieve similar purity with shorter processing time .

What are the typical yields and limitations of current P34 purification methods?

Yield considerations:

  • Total process yield (starting from soybeans): Approximately 2-3% of theoretical maximum

  • Chromatographic yield (starting from prepared feedstock): 18-27%

  • Major protein loss occurs during feedstock preparation: Only about 12% of theoretical P34 content reaches the chromatography step

Process performance metrics:

  • P34 content in soybeans: ~2% of total protein (theoretical maximum: ~7.8 mg pure P34 per gram soybean)

  • Best yield on 7.5 mL column: 173 μg pure P34 from 1 g soybeans (~2% total yield)

  • Yield on 75 mL column: 250 μg pure P34 per gram soybean (~3% total yield)

Limitations and considerations:

  • Significant protein loss during initial extraction (only 12% of theoretical P34 makes it to chromatography)

  • The relatively low yields are somewhat offset by the low cost and high availability of soybeans

  • Yield could potentially be improved through modifications to the preparation protocol

  • Consideration should be given to the trade-off between yield and purity when optimizing elution conditions

How can researchers confirm the identity and structural integrity of purified P34?

Multiple complementary techniques should be employed to verify P34 identity and quality:

  • Mass spectrometry-based identification:

    • Perform in-gel digestion of the protein band from SDS-PAGE

    • Analyze peptide fragments using LC-MS/MS

    • Use database analysis with software like MASCOT and protein databases (MSDB/NCBI) to confirm identity

  • Immunological verification:

    • Western blot analysis using P34-specific antibodies

    • ELISA-based detection methods

  • Glycosylation analysis:

    • Verify post-translational modifications including glycosylation status

    • Compare observed molecular weight with theoretical values to confirm proper processing

  • Structural integrity assessment:

    • Circular dichroism spectroscopy to assess secondary structure

    • Size exclusion chromatography to confirm monomeric/dimeric state

  • Functional characterization:

    • IgE binding assays to confirm allergenic epitopes are preserved

    • Assess association with oil bodies to confirm native-like behavior

These verification steps are critical to ensure that the purified protein maintains its native characteristics for valid experimental results.

What analytical techniques are most useful for studying P34 interactions with other molecules?

Researchers studying P34 interactions can employ these analytical approaches:

  • Surface plasmon resonance (SPR) for real-time binding kinetics with:

    • Immunoglobulins (particularly IgE)

    • Cell membrane components

    • Other seed proteins

  • Pull-down assays to identify:

    • Protein-protein interactions in seed extracts

    • Association with 7S globulin fraction proteins

  • Fluorescence-based techniques:

    • FRET (Förster resonance energy transfer) for proximity analysis

    • Fluorescence anisotropy for binding studies

  • Microscopy methods:

    • Immunogold labeling with electron microscopy to visualize P34 localization

    • Confocal microscopy with fluorescently labeled P34 to track cellular distribution

  • Computational approaches:

    • Molecular docking simulations to predict interaction interfaces

    • Molecular dynamics to understand structural flexibility

How should researchers design experiments to evaluate P34 allergenicity in comparison to other soybean proteins?

A comprehensive experimental design should include:

In vitro assessment protocols:

  • IgE binding assays:

    • Use sera from soy-allergic patients

    • Compare binding patterns between P34 and other soybean proteins

    • Include cross-reactivity analysis with structurally similar proteins

  • Basophil activation tests:

    • Expose basophils from allergic and non-allergic individuals to purified P34

    • Measure activation markers (CD63, CD203c)

    • Compare dose-response relationships with other allergens

  • Epitope mapping:

    • Identify specific allergenic epitopes using peptide arrays

    • Determine whether epitopes are sequential or conformational

    • Compare conservation of epitopes across similar proteins

Cellular response evaluation:

  • Dendritic cell activation:

    • Measure maturation markers and cytokine production

    • Assess antigen presentation capability

  • T cell proliferation assays:

    • Determine T cell epitopes

    • Measure cytokine profiles to assess Th1/Th2 balance

Comparative analysis framework:

  • Include both allergenic and non-allergenic proteins as controls

  • Use wild-type P34 and low-P34 variant comparisons

  • Standardize protein concentrations and experimental conditions

  • Implement blinded sample analysis where appropriate

What are the key considerations when investigating the impact of processing methods on P34 allergenicity?

When studying how food processing affects P34 allergenicity, researchers should address:

Processing variables to investigate:

  • Thermal processing:

    • Systematic temperature ranges (60-100°C)

    • Varied heating durations (5-60 minutes)

    • Dry vs. wet heating conditions

  • pH modifications:

    • Acidic (pH 2-4), neutral (pH 6-7), and alkaline (pH 8-10) conditions

    • Time-dependent effects at different pH values

  • Enzymatic treatments:

    • Proteolytic enzymes (trypsin, pepsin, etc.)

    • Glycosidases to modify glycan structures

  • Fermentation:

    • Different microbial cultures

    • Fermentation duration and conditions

Analytical endpoints:

  • Structural changes:

    • Secondary/tertiary structure alterations (CD spectroscopy, fluorescence)

    • Changes in glycosylation patterns

  • Functional changes:

    • IgE binding capacity before and after processing

    • Digestibility in simulated gastric and intestinal fluids

  • Cellular responses:

    • Changes in basophil activation potential

    • Dendritic cell maturation and T cell responses

Experimental design considerations:

  • Include time-course sampling to capture processing kinetics

  • Analyze both isolated P34 and P34 in food matrices

  • Consider combinatorial processing effects (e.g., heat + pH)

  • Include appropriate controls for each processing condition

How can transgenic approaches and gene editing be applied to modify P34 expression or structure?

Researchers exploring genetic modification approaches should consider:

CRISPR/Cas9 gene editing strategies:

  • Targeted mutations at the P34 start codon:

    • Mimic the natural four-basepair insertion found in low-P34 accessions

    • Create alternative start codon modifications to reduce expression

  • Epitope modification:

    • Identify and target specific allergenic epitopes

    • Introduce precise amino acid substitutions to reduce allergenicity while maintaining protein structure

  • Promoter modifications:

    • Reduce expression levels through promoter editing

    • Create tissue-specific expression patterns

RNAi and antisense approaches:

  • Construct design considerations:

    • Target P34 mRNA specifically without affecting related genes

    • Use seed-specific promoters to limit expression to relevant tissues

  • Evaluation parameters:

    • Measure reduction in P34 transcript levels

    • Confirm protein reduction in seeds

    • Assess any unintended consequences on seed development

Regulatory and safety assessment framework:

  • Comprehensive allergenicity testing of modified varieties

  • Compositional analysis to ensure no unintended changes

  • Agronomic performance evaluation

What experimental approaches best characterize the cellular mechanisms of P34-induced allergic responses?

To elucidate cellular mechanisms, researchers should design experiments addressing:

Antigen presentation and recognition:

  • Dendritic cell studies:

    • Investigate uptake and processing of P34

    • Identify receptors involved in recognition

    • Track intracellular trafficking pathways

  • T cell activation analysis:

    • Characterize T cell receptor (TCR) recognition of P34 epitopes

    • Map MHC-peptide-TCR interactions

    • Assess co-stimulatory signals required

Signaling pathway investigation:

  • Basophil and mast cell activation:

    • Map FcεRI-mediated signaling cascades

    • Identify specific phosphorylation events

    • Compare calcium mobilization patterns

  • Transcriptomic and proteomic approaches:

    • RNA-seq analysis of activated immune cells

    • Phosphoproteomics to map signaling networks

    • Single-cell analysis to capture cellular heterogeneity

Advanced in vitro models:

  • 3D tissue constructs:

    • Intestinal epithelial models with immune components

    • Air-liquid interface respiratory models for studying cross-reactivity

  • Microfluidic systems:

    • Organ-on-a-chip approaches to model allergen exposure

    • Real-time visualization of cellular interactions

These experimental approaches should be designed with appropriate controls, including comparison with other well-characterized allergens and non-allergenic proteins.

Product Science Overview

Introduction

Soybean (Glycine max) is a major source of edible oil and protein, widely used in human and animal nutrition. However, it contains several allergenic proteins that can cause allergic reactions in sensitive individuals. One of the major allergenic proteins in soybean is the P34 protein, also known as Gly m Bd 30K or Gly m 1 .

Structure and Properties

The P34 protein is a monomeric insoluble glycoprotein with an isoelectric point of 4.5 and an amino acid-based calculated mass of 28.643 Da . In its glycosylated form, the mass is slightly larger, resulting in a band of approximately 32 kDa in non-reduced SDS PAGE gels . P34 belongs to the papain family of thiol proteases and has an N-terminal amino acid sequence and composition identical to that of the seed 34kDa protein .

Allergenic Potential

P34 is recognized as the main allergen for soybean-sensitive humans . The incidence of adverse reactions to food antigens, including P34, is particularly high in children, ranging from 2-8%, compared to 1-2% in adults . The allergenic potential of P34 necessitates detailed studies to understand how food antigens reach immune cells and elicit allergic reactions.

Recombinant P34 Protein

Recombinant P34 protein is a valuable tool for analyzing antigen-specific responses in soybean allergy . It can be used in various applications, including the development of diagnostic methods and specific immunotherapy techniques for soybean allergy .

Molecular Mechanism of P34 Gene Expression

Recent studies have identified molecular mechanisms controlling P34 gene expression in soybean. For instance, two low-P34 soybean accessions, PI603570A and PI567476, were identified . Comparative analysis of P34 cDNAs and genomic sequences from low-P34 and normal soybean accessions revealed that genetic polymorphisms in P34 promoters significantly affect translation efficiency . Specifically, a 4-bp insertion in front of the start codon of the P34 gene in PI567476 leads to reduced translation efficiency and lower accumulation of P34 protein .

Purification of P34 Protein

A method for purifying soybean P34 protein using hydrophobic interaction chromatography has been developed . This technique allows for the production of pure P34 protein within a short timeframe, suitable for further studies where an example antigen is needed . The purification process involves using Butyl Sepharose 4 FF as the stationary phase and ammonium sulfate for gradient elution .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.